STTCOMP AGX, FA LONG
MC $3 million
SP 2.1c
Cash approx $1.6 million after the recent repatriation of funds from China
Annual cash burn down to $300k
SOI 157.3 million
May not be long before this shell goes into a TH........ During 2015 the Company focused on divesting its suite of existing medical projects in order to pursue a new direction.
They have been reviewing many businesses throughout 2015 and conducting due diligence.
The repatriation of funds from China now enhances their ability of the Company to secure alternative strategies.
Adam Gallagher from Scintilla Strategic Investments on the board and T20.
Lindsay Carthew T20 and is a philanthropist for the molecular sciences at Adelaide University.
AGX already in "Pharmaceuticals, Biotechnology & Life Sciences" sector........the question is will they stay in that sector??
